Overview

The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The objective of this protocol is to analyze the sensitivity and specificity of 18F-DTBZ PET to the differential diagnosis of Parkinson's disease (PD) and other parkinsonism disorders, including multiple system atrophy (MSA), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP).
Phase:
Phase 2
Details
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborator:
National Science Council, Taiwan
Treatments:
Fluorodeoxyglucose F18